Speakers

Sort by
Newest
Trending
1-22 of 22
Filter
Sherry Yafai, MD
Emergency Medicine Physician at The RELEAF Institute
addiction, arthritis, attention deficit hyperactivity disorder, cannabis, cannabis (drug), cannabis sativa, dose (biochemistry), electronic cigarette, emergency department, emergency medicine, heroin, ibuprofen, naproxen, off-label use, opioid, opioid use disorder, over-the-counter drug, pain management, paracetamol, physician, psychoactive drug, residency (medicine), substance dependence, uc san diego school of medicine, world wide web
Jimmy Castillo
Chief Innovation Officer at Jenny's Rose
cancer, cannabidiol, cannabinoid, cannabis, chemotherapy, dietary supplement, dose (biochemistry), dose (biochemistry)?, doses (biochemistry), endocannabinoid system, entourage effect, fat, ginger, medication, medicinal plants, opiate, opioid, pain management, pharmacy, physician, prescription drug, rheumatology, rose, systemic lupus erythematosus, tetrahydrocannabinol, turmeric, vitamin c
Jessie Kempf
Co-Founder at Mend
cancer, cannabidiol, cannabinoid, cannabis, chemotherapy, dietary supplement, dose (biochemistry), dose (biochemistry)?, doses (biochemistry), endocannabinoid system, entourage effect, fat, ginger, medication, medicinal plants, opiate, opioid, pain management, pharmacy, physician, prescription drug, rheumatology, rose, systemic lupus erythematosus, tetrahydrocannabinol, turmeric, vitamin c
Nicole Davidsohn
Co-Founder & Formulator at Eva
agriculture, attention, ayurveda, cancer, cannabidiol, cannabinoid, cannabis, chemotherapy, china, chinese herbology, dietary supplement, dose (biochemistry), dose (biochemistry)?, doses (biochemistry), drug, endocannabinoid system, entourage effect, fat, flower, food, food and drug administration, ginger, grocery store, heat, hemp, medication, medicinal plants, news, nutraceutical, opiate, opioid, pain management, percentage, pesticide, pharmaceutical industry, pharmacy, physician, prescription drug, retail, rheumatology, rose, runway, seed, systemic lupus erythematosus, tetrahydrocannabinol, traditional chinese medicine, turmeric, united states department of agriculture, vitamin c
Guy Rocourt
Co-Founder & Chief Product Officer at Papa and Barkley
1996 california proposition 215, agriculture, analytics, antioxidant, apple, biochar, biodiesel, brand, brewery, business model, butter, calibration, cancer, candy, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis sativa, certificate of analysis, chemical engineering, chemist, chemotherapy, chromatography, classified information, clinical trial, coconut oil, colorado, compliance training, critical mass, cultivar, dietary supplement, dominance (genetics), dose (biochemistry), dose (biochemistry)?, doses (biochemistry), electrical equipment in hazardous areas, electronic cigarette, endocannabinoid system, engineering, entourage effect, ethanol, farm, farmer, fat, fda warning letter, feeling, flower, food, food and drug administration, freeze-drying, generally recognized as safe, ginger, good manufacturing practice, gummy candy, hash oil, hashish, hemp, herb, high-performance liquid chromatography, ice, impatiens necrotic spot virus, infection, intrinsic safety, inventory, irrigation in viticulture, juice, laboratory, laboratory., lavandula, liquid, market (economics), marketplace, median lethal dose, medication, medicinal plants, mining, monopoly, natural selection, nuclear magnetic resonance spectroscopy, nutraceutical, occupational safety and health, occupational safety and health administration, oil refinery, olive, olive oil, ontario, opiate, opioid, orange juice, organic compound, over-the-counter drug, packaging, and labeling, pain management, pathogen, pepsi, personal protective equipment, pharmaceutical industry, pharmacovigilance, pharmacy, phase (matter), phenotype, physician, phytochemical, piano, plant, plant breeding, plant nursery, plant tissue culture, plant virus, plumbing, prescription drug, pressure vessel, quality management system, rancidification, reason, regulatory compliance, rheumatology, root, rose, rosin, scott gottlieb, sedative, shelf life, shore durometer, south carolina, soybean, steel, steel-toe boot, supermarket, systemic lupus erythematosus, tax, technology, terpene, terroir, tetrahydrocannabinol, theory, tree, trichome, turmeric, united states farm bill, vegetative reproduction, vermont, virus, vitamin c, vitamin e, vitis, volatile organic compound, warehouse, washing machine, water, wheat, whole foods market, xfinity
Kayla Fioravanti
Business Owner at Ology Essentials
aromatherapy, bank, big data, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis sativa, clinical trial, craft brewery and microbrewery, crop insurance, curriculum, customer, dose (biochemistry), evidence-based medicine, finance, food, food and drug administration, goal, herb, medical cannabis, medical prescription, medication, mirror, molecule, organized crime, pain management, payment, pharmaceutical industry, placebo, placebo-controlled study, prescription drug, scientific method, stress (biology), taste, tetrahydrocannabinol, thalidomide, water, whole foods market, wine, wood
Allen Manison
Chief Science Officer at Noetic Nutraceuticals, LLC
adipose tissue, antidepressant, aromatherapy, arthritis, bank, brain damage, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), chronic condition, chronic pain, clinical trial, crop insurance, curriculum, dose (biochemistry), endocannabinoid system, evidence-based medicine, fibromyalgia, finance, food and drug administration, immune system, inflammation, lymphocyte, major depressive disorder, medical cannabis, medical prescription, medication, organized crime, pain disorder, pain management, payment, pharmaceutical industry, placebo-controlled study, prescription drug, psychotherapy, tetrahydrocannabinol, tetrahydrocannabinol acid
Randy Fink
Physician, Medical Director at Miami Center of Excellence, LLC
alternative medicine, anesthesia, antihypertensive drug, anxiety, arm, aromatherapy, bank, bioidentical hormone replacement therapy, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, cannabis sativa, clinical trial, crohn's disease, crop insurance, curriculum, depression (mood), diarrhea, dose (biochemistry), endocannabinoid system, entourage effect, erection, evidence-based medicine, finance, food and drug administration, gastrointestinal disease, general surgery, gums, hemp, human sexual activity, ileostomy, inflammatory bowel disease, libido, medical cannabis, medical prescription, medication, mind, organized crime, orgasm, pain management, payment, pharmaceutical industry, pharmacology, pharmacy, placebo-controlled study, prescription drug, psychoactive drug, retail, route of administration, tadalafil, terminal illness, tetrahydrocannabinol, therapeutic index, transgender hormone therapy (male-to-female), ulcerative colitis
Carlton Bone
Founder at Upward Cannabis Kitchen
adolescence, alternative medicine, anesthesia, antibiotic, anticoagulant, anticonvulsant, antifungal, antihypertensive drug, appetite, aromatherapy, bank, bicycle, biotechnology, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, certificate of analysis, chemotherapy, clinical trial, concept, crohn's disease, crop insurance, curriculum, curveball, cvs pharmacy, dementia, depression (mood), diarrhea, dose (biochemistry), drink, drug development, endocannabinoid system, engineer, entourage effect, evidence-based medicine, family medicine, fibromyalgia, finance, food and drug administration, gastrointestinal disease, general surgery, good manufacturing practice, headache, ileostomy, inflammation, inflammatory bowel disease, market (economics), medical cannabis, medical prescription, medication, neurology, nutraceutical, opioid, opioid epidemic in the united states, organized crime, over-the-counter drug, pain management, payment, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, placebo-controlled study, prescription drug, psychoactive drug, race (human categorization), reverse engineering, route of administration, sense, sensitivity and specificity, slider (baseball), stroke, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, therapeutic index, thrombus, ulcerative colitis, washington (state)
Jake Black
Chief Scientific Officer at Treehouse Biotech
accuracy and precision, analgesic, anesthesia, animal testing, aromatherapy, attention, big data, biochemistry, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis sativa, cannabis strain, carbon dioxide, carboxylic acid, cell (biology), certificate of analysis, certification, chemistry, chemotherapy, chromatography, circulatory system, cocaine, court, data, dietary supplement, dose (biochemistry), drug overdose, drug rehabilitation, drug test, electric battery, electronic cigarette, endocannabinoid system, entourage effect, enzyme, essential oil, ethanol, food, food and drug administration, fungus, gas chromatography, glyphosate, greenhouse gas, hemp, herb, herbal medicine, inquiry, international organization for standardization, iso/iec 17025, kashrut, life, lipid bilayer, major depressive disorder, mass, measurement uncertainty, medical cannabis, medication, mercury (element), mood (psychology), mood disorder, natural product, nutrient, odor, olfaction, opiate, opioid, over-the-counter drug, pain, pain management, parts-per notation, perfume, personalized medicine, pesticide, pesticide residue, pharmaceutical industry, pharmacology, placebo, prescription drug, product liability, propagation of uncertainty, protein structure, protein structures, protein-protein interaction, protein–protein interaction, quantification (science), regulatory compliance, reliability engineering, reputation, research, science, solvent, stress (biology), substance dependence, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinol acid, traceability, uncertainty, united states pharmacopeia, validity (statistics), vaporizer (inhalation device), vitamin, water, whole foods market
Hinaxi Patel
Technical Director at Brightside Scientic Inc
attention, cannabidiol, cannabinoid, cannabinoid receptor, cannabis, cannabis (drug), cannabis indica, cannabis sativa, cannabis strain, dietary supplement, drug overdose, drug rehabilitation, endocannabinoid system, ethanol, food and drug administration, medication, mood (psychology), opiate, opioid, pain management, pharmaceutical industry, prescription drug, stress (biology), substance dependence, tetrahydrocannabinol
Ray Mirzabegian
President at CW California Inc / Canniatric Inc
attention, cannabidiol, cannabinoid, cannabinoid receptor, cannabis, cannabis (drug), cannabis indica, cannabis sativa, cannabis strain, dietary supplement, drug overdose, drug rehabilitation, endocannabinoid system, ethanol, food and drug administration, medication, mood (psychology), opiate, opioid, pain management, pharmaceutical industry, prescription drug, stress (biology), substance dependence, tetrahydrocannabinol
Robert Davis
Senior Scientist at Treehouse Biotech
alexander fleming, attention, bombardier beetle, cannabidiol, cannabinoid, cannabinoid receptor, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis sativa, cannabis strain, chemical ecology, crispr, decarboxylation, dietary supplement, dna, dna sequencing, drug overdose, drug rehabilitation, endocannabinoid system, enzyme, ethanol, food and drug administration, genetically modified organism, insect, insecticide, medication, mimicry, mood (psychology), nicotine, opiate, opioid, pain management, pharmaceutical industry, pollination, prescription drug, protein, smoking, stress (biology), substance dependence, terpene, tetrahydrocannabinol, tonic water, virus
Keiko Beatie
Director of Education & Programming Coral Cove Cannabis Jamaica Holistic Ayurvedic Chinese Medicine at Green Wave Relations
absorption (pharmacology), acne, aesthetics, agriculture, allergy, american broadcasting company, anxiety, anxiety disorder, arthritis, attention, ayurveda, belief, bioavailability, brand, broadcast syndication, cake, cancer, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cbs, certificate of analysis, chemical peel, china, chinese herbology, chronic pain, chronic stress, clinical trial, cortisol, cosmetics, crohn's disease, cytokine, dementia, design, dietary supplement, dose (biochemistry), drug, drug overdose, drug rehabilitation, endocannabinoid system, ethanol, federal aviation administration, flower, food, food allergy, food and drug administration, fox broadcasting company, gastrointestinal tract, good manufacturing practice, grapefruit–drug interactions, grocery store, haircare, health care, heat, hemp, herbal medicine, hypertension, law, lawyer, lotion, medical cannabis, medication, medicine, medium-chain triglyceride, mental disorder, mood (psychology), nbc, news, nutraceutical, opiate, opioid, organic certification, osteoarthritis, packaging and labeling, packaging, and labeling, pain, pain management, percentage, pesticide, pharmaceutical industry, prescription drug, pricing, psilocybin, qr code, reputation, retail, route of administration, runway, seed, separation anxiety disorder, shelf life, soap, solubility, stress (biology), substance dependence, tablet (pharmacy), tea, tetrahydrocannabinol, textbook, therapy, traditional chinese medicine, tumor necrosis factor-alpha, united states department of agriculture, veterinarian
James Schwartz
CEO at Cascade High
agriculture, antibiotic, aromatherapy, bacteria, bank, brand, california, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis sativa, certificate of analysis, charlotte's web (cannabis), clinical trial, coeliac disease, compost, convenience store, counterfeit consumer goods, crop insurance, curriculum, dietary supplement, distribution (marketing), dose (biochemistry), due diligence, ecosystem, electronic cigarette, endocannabinoid system, endocrine system, evidence-based medicine, farmer, fertilizer, finance, food, food and drug administration, gardening, gene, genetically modified crops, genetically modified food, genetically modified organism, genetics, gluten, gluten-related disorders, glyphosate, glyphosates, go to market, good manufacturing practice, health care, hemp, homeostasis, integrated pest management, irritable bowel syndrome, lawyer, maize, mediation, medical cannabis, medical prescription, medication, natural environment, nervous system, nothing, online advertising, organic certification, organic farming, organic matter, organized crime, overtime, packaging and labeling, packaging, and labeling, pain management, pansy, password, patient, payment, pest control, pesticide, pharmaceutical industry, placebo-controlled study, plant breeding, plastic, prescription drug, pricing, psychoactive drug, question, recycling, retail, safety, sampling (statistics), self-medication, shelf life, smoking, social media, soil, supply chain, sustainability, sustainable agriculture, sympathetic nervous system, tetrahydrocannabinol, titanium, tomato, traceability, tree, united states department of agriculture, united states postal service, vaporizer (inhalation device), water content
Melanie Bone
Physician and Educator at 2nd.MD
anticoagulant, benzodiazepine, bioavailability, bleeding, cannabinoid, cannabis (drug), dose (biochemistry), edema, food and drug administration, indication (medicine), medical cannabis, morphine, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, pharmaceutical industry, physician, placebo-controlled study, rhabdomyosarcoma, spasticities, tetrahydrocannabinol, therapeutic index, warfarin
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anticoagulant, antipsychotic, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, budtender, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, certificate of analysis, depression (mood), dispensary, dopamine, dose (biochemistry), dravet syndrome, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, fibromyalgia, food and drug administration, free market, good manufacturing practice, gpr55, hair loss, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medicine, mental disorder, mental health, methotrexate, morphine, norepinephrine, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, pharmaceutical industry, pharmacology, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, randomized controlled trial, rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, serotonin, spasticities, sports medicine, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vaporizer (inhalation device), warfarin
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
Jerome Julian Grove
Co-Founder at The Physician's Choice CBD
alprazolam, alternative medicine, amitriptyline, analgesic, anesthesia, antihypertensive drug, arthritis, benzodiazepine, benzodiazepine withdrawal syndrome, buprenorphine, buprenorphine/naloxone, cancer, cannabinoid, carisoprodol, chiropractic, complex regional pain syndrome, crohn's disease, cyclobenzaprine, depression (mood), diabetic neuropathy, diarrhea, diazepam, diclofenac, dose (biochemistry), entourage effect, fentanyl, forecoxa, gabapentin, gastrointestinal disease, general surgery, harm reduction, heroin, ibuprofen, ileostomy, inflammatory bowel disease, lorazepam, medical cannabis, medical prescription, medication, meloxicam, methadone, muscle relaxant, naproxen, opiate, opioid, opioid epidemic in the united states, opioid use disorder, over-the-counter drug, oxycodone/paracetamol, pain management, paracetamol, paresthesia, peripheral neuropathies, peripheral neuropathy, pharmacology, pregabalin, psychoactive drug, rheumatology, route of administration, substance dependence, systemic lupus erythematosus, tapenade, terminal illness, tetrahydrocannabinol, therapeutic index, tramadol, ulcerative colitis
Dexter Russell
CEO at Naprapathic Health Solutions
alprazolam, analgesic, anesthesia, benzodiazepine, benzodiazepine withdrawal syndrome, buprenorphine, buprenorphine/naloxone, carisoprodol, chiropractic, diazepam, fentanyl, harm reduction, heroin, lorazepam, methadone, muscle relaxant, opiate, opioid, opioid epidemic in the united states, opioid use disorder, oxycodone/paracetamol, pain management, peripheral neuropathy, pregabalin, substance dependence
Christian Shaw
Christian Shaw at REBEL MD
alprazolam, analgesic, anesthesia, benzodiazepine, benzodiazepine withdrawal syndrome, buprenorphine, buprenorphine/naloxone, carisoprodol, chiropractic, diazepam, fentanyl, harm reduction, heroin, lorazepam, methadone, muscle relaxant, opiate, opioid, opioid epidemic in the united states, opioid use disorder, oxycodone/paracetamol, pain management, peripheral neuropathy, pregabalin, substance dependence
Kristina Etter
Editorial Content Director at Cannabis Tech
alprazolam, analgesic, anesthesia, benzodiazepine, benzodiazepine withdrawal syndrome, buprenorphine, buprenorphine/naloxone, carisoprodol, chiropractic, diazepam, fentanyl, harm reduction, heroin, lorazepam, methadone, muscle relaxant, opiate, opioid, opioid epidemic in the united states, opioid use disorder, oxycodone/paracetamol, pain management, peripheral neuropathy, pregabalin, substance dependence
1